Evidence map›Paper›PMID 25053865›Full record

ReviewSeminars in interventional radiology2014

Bone and soft tissue ablation.

Ryan C B Foster, Joseph M Stavas

Open access · bronzeAbstract readReview
In one paragraph

Review in Seminars in interventional radiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Review
  5. Review
  6. Clinical Experience of Percutaneous Radiofrequency Ablation Using an arfa RF ABLATION SYSTEMInterventional radiology (Higashimatsuyama-shi (Japan) · 2022
    Article
  7. Review
  8. Article
  9. Combinatorial effect of radium-223 and irreversible electroporation on prostate cancer bone metastasis in mice.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Real-time probe tracking using EM-optical sensor for MRI-guided cryoablation.The international journal of medical robotics + computer assisted surgery : MRCAS · 2018
    Article
  16. Article
  17. Article
  18. Bone Pain and Muscle Weakness in Cancer Patients.Current osteoporosis reports · 2017
    Review
  19. Article
  20. Radiofrequency Ablation of Uterine Fibroids: a Review.Current obstetrics and gynecology reports · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Ryan C B FosterDepartment of Radiology, Hospital for Special Surgery, New York, New York.
Joseph M StavasDepartment of Radiology, the University of North Carolina, Chapel Hill, North Carolina.
Hospital for Special Surgery · USUniversity of North Carolina at Chapel Hill · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone and soft tissue tumor ablation has reached widespread acceptance in the locoregional treatment of various benign and malignant musculoskeletal (MSK) lesions. Many principles of ablation learned elsewhere in the body are easily adapted to the MSK system, particularly the various technical aspects of probe/antenna design, tumoricidal effects, selection of image guidance, and methods to reduce complications. Despite the common use of thermal and chemical ablation procedures in bone and soft tissues, there are few large clinical series that show longitudinal benefit and cost-effectiveness compared with conventional methods, namely, surgery, external beam radiation, and chemotherapy. Percutaneous radiofrequency ablation of osteoid osteomas has been evaluated the most and is considered a first-line treatment choice for many lesions. Palliation of painful metastatic bone disease with thermal ablation is considered safe and has been shown to reduce pain and analgesic use while improving quality of life for cancer patients. Procedure-related complications are rare and are typically easily managed. Similar to all interventional procedures, bone and soft tissue lesions require an integrated approach to disease management to determine the optimum type of and timing for ablation techniques within the context of the patient care plan.

Indexed as

bone and soft tissuecryoablationinterventional radiologymicrowave ablationradiofrequency ablationtumors

Identifiers

PMID25053865
PMCPMC4078106
OpenAlexW2079585502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.